These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25145509)

  • 41. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia.
    Peterson AL; McNeal CJ; Wilson DP
    Curr Atheroscler Rep; 2021 Aug; 23(10):64. PubMed ID: 34453222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit].
    Chemaly P; Nallet O; Delarche N; Legagneur C; Boulestreau R; Reibel I; Palette C; Grenier A; Courtade H; Beaune G; Belle L; Georges JL
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):300-309. PubMed ID: 30290906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring Costs of Cardiovascular Disease Prevention for Patients with Familial Hypercholesterolemia in Administrative Claims Data.
    Passero LE; Roberts MC
    High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):215-219. PubMed ID: 38308804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Genetic principles of food related problems--familial hypercholesterolaemia].
    Floré M; Robberecht N; Hermans H
    J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679
    [No Abstract]   [Full Text] [Related]  

  • 47. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypercholesterolemia in children: Why and how to screen for it?
    Girardet JP; Bocquet A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Rozé JC; Simeoni U; Turck D; Briend A; Dupont C;
    Arch Pediatr; 2018 Apr; 25(3):175-176. PubMed ID: 29548557
    [No Abstract]   [Full Text] [Related]  

  • 49. How Can We Improve the Diagnosis Rate of Familial Hypercholesterolemia by Amending Diagnosis Criteria?
    Harada-Shiba M
    Circ J; 2021 May; 85(6):898-899. PubMed ID: 33762528
    [No Abstract]   [Full Text] [Related]  

  • 50. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial Hypercholesterolemia: Although Identification Advances, Appreciation and Treatment Lag.
    Baum SJ; Brown AS
    Rev Cardiovasc Med; 2018; 19(S1):S25-S30. PubMed ID: 30207555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of children with heterozygous familial hypercholesterolemia.
    Reiner Ž; Sahebkar A
    Int J Cardiol; 2020 Apr; 304():177-178. PubMed ID: 31735366
    [No Abstract]   [Full Text] [Related]  

  • 54. Reverse Cascade Screening for Familial Hypercholesterolemia.
    Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
    J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for familial hypercholesterolemia: a model for preventive medicine.
    Mata P; Alonso R; Pérez-Jiménez F
    Rev Esp Cardiol (Engl Ed); 2014 Sep; 67(9):685-8. PubMed ID: 25172062
    [No Abstract]   [Full Text] [Related]  

  • 56. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines.
    Palma L; Welding M; OʼShea J
    Nurse Pract; 2016 Aug; 41(8):36-43. PubMed ID: 27414814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.
    Brunham LR; Ruel I; Aljenedil S; Rivière JB; Baass A; Tu JV; Mancini GBJ; Raggi P; Gupta M; Couture P; Pearson GJ; Bergeron J; Francis GA; McCrindle BW; Morrison K; St-Pierre J; Henderson M; Hegele RA; Genest J; Goguen J; Gaudet D; Paré G; Romney J; Ransom T; Bernard S; Katz P; Joy TR; Bewick D; Brophy J
    Can J Cardiol; 2018 Dec; 34(12):1553-1563. PubMed ID: 30527143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal management of familial hypercholesterolemia: treatment and management strategies.
    Nemati MH; Astaneh B
    Vasc Health Risk Manag; 2010 Dec; 6():1079-88. PubMed ID: 21191428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Familial hypercholesterolemia. Screening, prevention and therapeutic possibilities].
    Vierucci A; Biadaioli R; De Martino M; Pratesi F; Novembre E; Morotti P
    Minerva Pediatr; 1982 Apr; 34(8):325-36. PubMed ID: 7048049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.